INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 10th April, 2020 on account of Good Friday.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3%
Thu, 6 Jun

INDOCO REMEDIES has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m2,6962,6262,520-4.0%-6.5%
Other incomeRs m10649766.7%375.0%
TurnoverRs m2,7072,6312,570-2.3%-5.1%
ExpensesRs m2,2022,3782,235-6.0%1.5%
Gross profitRs m49424828615.2%-42.2%
DepreciationRs m1631771959.8%19.2%
InterestRs m83374624.5%-44.4%
Profit before taxRs m2583994141.0%-63.6%
TaxRs m53-14-22-142.1%
Profit after taxRs m20553116117.8%-43.3%
Gross profit margin%18.39.411.3
Effective tax rate%20.5-36.9-23.7
Net profit margin%7.62.04.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 6.5% on a year-on-year (YoY) basis. The expenses were up by 1.5% YoY during the same period.
  • The company's operating profit declined by 42.2% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 11.3% in 4QFY19 as against 18.3% in 4QFY18.
  • Depreciation charges increased by 19.2% and finance costs declined by 44.4% YoY, respectively.
  • Other income increased by 375.0% YoY during the quarter.
  • Net profit for the quarter declined by 43.3% YoY. Net profit margins during the quarter declined from 7.6% in 4QFY18 to 4.5% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 4.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 6.0% QoQ during the same period.
  • The company's operating profit increased by 15.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 11.3% in 4QFY19 as against 9.4% in 3QFY18.
  • Net profit for the quarter increased by 117.8% QoQ, while net profit margins increased from 2.0% in 3QFY18 to 4.5% in 4QFY19.

To see how INDOCO REMEDIES has performed over the last eight quarters, please visit here.

INDOCO REMEDIES Share Price Performance

Over the last one year, INDOCO REMEDIES share price has moved up from Rs 186.7 to Rs 176.2, registering a Loss of Rs 10.5 or around 5.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,228.7 (down 0.5%). Over the last one year it has moved up from 12,859.1 to 13,228.7, a gain of 370 points (up 2.9%).

Overall, the S&P BSE SENSEX is up 14.2% over the year.

Current Valuations

At the current price of Rs 176.2, the price to book value (P/BV) ratio of INDOCO REMEDIES stands at 2.4 times.

Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3%". Click here!

  

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (3QFY20); Net Profit Up 74.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

A Safe Stock to Lockdown Now(The 5 Minute Wrapup)

Apr 2, 2020

The market crashc has made strong, established brands attractive. Here's a stock to make the most of this opportunity...

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

This Smallcap Tech Firm has Risen to the Coronavirus Challenge(Profit Hunter)

Apr 7, 2020

This smallcap tech firm is all set to emerge stronger from the Coronavirus crisis.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Apr 9, 2020 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - COX & KINGS COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS